Announcements Trials
Browse Landscape

Status

Recruiting 2Completed 2

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 87Observational 4

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 2Advanced Breast Cancer 2

Interventions

Surveys and Questionnaires 53Blood Specimen Collection 53Specimen Handling 28Radiotherapy 18Observation 18Interviews as Topic 13Magnetic Resonance Spectroscopy 12Surgical Procedures, Operative 10Drug Therapy 10Data Collection 10Biopsy 10Tomography, X-Ray Computed 9darolutamide 8Watchful Waiting 7Standard of Care 7ribociclib 6palbociclib 6Restraint, Physical 6Patient Reported Outcome Measures 6Magnetic Resonance Imaging 6Immune Checkpoint Inhibitors 6trastuzumab deruxtecan 5Positron-Emission Tomography 5Mass Screening 5Genetic Testing 5Esophagectomy 5Breath Tests 5Bevacizumab 5enzalutamide 4apalutamide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Letrozole × 90 days × Clear all
NCT06930859 2026-05-22

ELEGANCE

Novartis

Recruiting
2,766 enrolled
Breast

Breast Neoplasms

NCT07178743 2026-05-12

Emulation of the PALOMA-2 Trial

Brigham and Women's Hospital

Completed
6,097 enrolled
Breast

Advanced Breast Cancer

NCT07225790 2026-05-12

Emulation of the MONARCH-3 Trial Using Specialty Oncology Electronic Health Records Databases

Brigham and Women's Hospital

Completed
3,883 enrolled
Breast

Advanced Breast Cancer

NCT06905301 2026-05-05

IMPULSE

Novartis

Recruiting
240 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡